记忆缺失评估

Budson AE, Price BH. Memory dysfunction. N Engl J Med. 2005 Feb 17;352(7):692-9.

• 摘要

McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013 Jan;136(Pt 1):43-64.

• 全文
• 摘要

Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63-74.

• 全文
• 摘要

Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Semin Neurol. 2008 Sep;28(4):467-83.

• 全文
• 摘要

Irani SR, Vincent A. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Arq Neuropsiquiatr. 2012 Apr;70(4):300-4.

• 全文
• 摘要

Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008 Mar;14(2):100-7.

• 摘要

McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005 Sep;4(9):543-55.

• 摘要

Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 Mar;127(Pt 3):701-12.

• 全文
• 摘要

Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006 Jul;129(Pt 7):1640-58.

• 全文
• 摘要

1.  McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939-44.

• 摘要

2.  Karlawish JH, Clark CM. Diagnostic evaluation of elderly patients with mild memory problems. Ann Intern Med. 2003 Mar 4;138(5):411-9.

• 摘要

3.  Kalisch Ellett LM, Pratt NL, Ramsay EN, et al. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J Am Geriatr Soc. 2014 Oct;62(10):1916-22.

• 摘要

4.  Zeng L, Josephson SA, Fukuda KA, et al. A prospective comparison of informant-based and performance-based dementia screening tools to predict in-hospital delirium. Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):312-6.

• 全文
• 摘要

5.  Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145.

• 全文
• 摘要

6.  Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8.

• 摘要

7.  Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Cochrane Database Syst Rev. 2018 Feb 22;(2):CD011415.

• 全文
• 摘要

8.  Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 Mar;56(3):303-8.

• 全文
• 摘要

9.  Barnes DE, Whitmer RA, Yaffe K. Physical activity and dementia: the need for prevention trials. Exerc Sport Sci Rev. 2007 Jan;35(1):24-9.

• 摘要

10.  Budson AE, Price BH. Memory dysfunction. N Engl J Med. 2005 Feb 17;352(7):692-9.

• 摘要

11.  Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29.

• 全文
• 摘要

12.  McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013 Jan;136(Pt 1):43-64.

• 全文
• 摘要

13.  Nordström A, Nordström P. Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study. PLoS Med. 2018 Jan 30;15(1):e1002496.

• 全文
• 摘要

14.  Lim C, Alexander MP, LaFleche G, et al. The neurological and cognitive sequelae of cardiac arrest. Neurology. 2004 Nov 23;63(10):1774-8.

• 摘要

15.  Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol. 2009 Mar-Apr;44(2):155-65.

• 全文
• 摘要

16.  Stojsavljevic N, Levic Z, Drulovic J, et al. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology. 1997 Sep;49(3):878-81.

• 摘要

17.  Kuljic-Obradovic D, Labudovic G, Basurovic N, et al. Neuropsychological deficits after bithalamic hemorrhages. J Neurol Sci. 2007 Jun 15;257(1-2):174-6.

• 摘要

18.  Karussis D, Leker RR, Abramsky O. Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature. J Neurol Sci. 2000 Jan 1;172(1):25-9.

• 摘要

19.  Lewis SL. Aetiology of transient global amnesia. Lancet. 1998 Aug 1;352(9125):397-9.

• 摘要

20.  Basnyat B, Wu T, Gertsch JH. Neurological conditions at altitude that fall outside the usual definition of altitude sickness. High Alt Med Biol. 2004 Summer;5(2):171-9.

• 摘要

21.  Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007 Jul 10;69(2):156-65.

• 摘要

22.  Snyder CH. Coccidioidal meningitis presenting as memory loss. J Am Acad Nurse Pract. 2005 May;17(5):181-6.

• 摘要

23.  Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003 Feb;60(2):164-71.

• 全文
• 摘要

24.  Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb;63(2):197-202.

• 全文
• 摘要

25.  Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. Neurologist. 2007 May;13(3):140-7.

• 摘要

26.  Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63-74.

• 全文
• 摘要

27.  McKeon A, Lennon VA, Pittock SJ. Immunotherapy-responsive dementias and encephalopathies. Continuum (Minneap Minn). 2010 Apr;16(2 Dementia):80-101.

• 摘要

28.  Rosenfeld MR, Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol. 2011 Jun;13(3):324-32.

• 全文
• 摘要

29.  Cirignotta F, Manconi M, Mondini S, et al. Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity: report of a case. Arch Neurol. 2000 Sep;57(9):1356-9.

• 摘要

30.  Quinn TJ, Fearon P, Noel-Storr AH, et al. Informant questionnaire on cognitive decline in the elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014 Apr 10;(4):CD010079.

• 全文
• 摘要

31.  Harrison JK, Fearon P, Noel-Storr AH, et al. Informant questionnaire on cognitive decline in the elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev. 2015 Mar 10;(3):CD010772.

• 全文
• 摘要

32.  Nelson PT, Jicha GA, Kryscio RJ, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol. 2010 Mar;257(3):359-66.

• 全文
• 摘要

33.  Paterson RW, Torres-Chae CC, Kuo AL, et al. Differential diagnosis of jakob-creutzfeldt disease. Arch Neurol. 2012 Dec;69(12):1578-82.

• 全文
• 摘要

34.  Lee SE, Rabinovici GD, Mayo MC, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011 Aug;70(2):327-40.

• 全文
• 摘要

35.  Giza CC, Kutcher JS, Ashwal S, et al. Summary of evidence-based guideline update: evaluation and management of concussion in sports: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 Jun 11;80(24):2250-7.

• 全文
• 摘要

36.  McKee AC, Daneshvar DH, Alvarez VE, et al. The neuropathology of sport. Acta Neuropathol. 2014 Jan;127(1):29-51.

• 全文
• 摘要

37.  Holsinger T, Deveau J, Boustani M, et al. Does this patient have dementia? JAMA. 2007 Jun 6;297(21):2391-404.

• 摘要

38.  Krueger CE, Kramer JH. Neurocognitive assessment. Continuum (Minneap Minn). 2010 Apr;16(2 Dementia):176-90.

• 摘要

39.  Haubois G, de Decker L, Annweiler C, et al. Derivation and validation of a short form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint. Eur J Neurol. 2013 Mar;20(3):588-90.

• 摘要

40.  Haubois G, Annweiler C, Launay C, et al. Development of a short form of Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint: a case control study. BMC Geriatr. 2011 Oct 4;11:59.

• 全文
• 摘要

41.  Schroeder RW, Twumasi-Ankrah P, Baade LE, Marshall PS. Reliable Digit Span: a systematic review and cross-validation study. Assessment. 2012 Mar;19(1):21-30.

• 摘要

42.  Jackson TA, Naqvi SH, Sheehan B. Screening for dementia in general hospital inpatients: a systematic review and meta-analysis of available instruments. Age Ageing. 2013 Nov;42(6):689-95.

• 全文
• 摘要

43.  Mitchell AJ, Malladi S. Screening and case finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests. Am J Geriatr Psychiatry. 2010 Sep;18(9):759-82.

• 摘要

44.  Derby CA, Burns LC, Wang C, et al. Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology. 2013 Apr 2;80(14):1307-14.

• 全文
• 摘要

45.  Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review) - report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1143-53.

• 摘要

46.  Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Semin Neurol. 2008 Sep;28(4):467-83.

• 全文
• 摘要

47.  National Institute for Health and Care Excellence. Head injury: assessment and early management. June 2017 [internet publication].

• 全文

48.  Goto H, Ishii K, Uemura T, et al. Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol. 2010 Apr;31(4):720-5.

• 全文
• 摘要

49.  Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007 Apr 10;68(15):1205-12.

• 摘要

50.  Rabinovici GD, Rosen HJ, Alkalay A, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 2011 Dec 6;77(23):2034-42.

• 全文
• 摘要

51.  Choi SR, Golding G, Zhuang Z, et al. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med. 2009 Nov;50(11):1887-94.

• 全文
• 摘要

52.  Clark CM, Pontecorvo MJ, Beach TG, et al; AV-45-A16 Study Group. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol. 2012 Aug;11(8):669-78.

• 摘要

53.  Doraiswamy PM, Sperling RA, Coleman RE, et al; AV45-A11 Study Group. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 2012 Oct 16;79(16):1636-44.

• 全文
• 摘要

54.  Fleisher AS, Chen K, Liu X, et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol. 2011 Nov;68(11):1404-11.

• 摘要

55.  Johnson KA, Sperling RA, Gidicsin CM, et al; AV45-A11 study group. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013 Oct;9(5 suppl):S72-83.

• 全文
• 摘要

56.  Martínez G, Vernooij RW, Fuentes Padilla P, et al. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017 Nov 22;(11):CD012216.

• 全文
• 摘要

57.  Martínez G, Vernooij RW, Fuentes Padilla P, et al. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017 Nov 22;(11):CD012883.

• 全文
• 摘要

58.  Martínez G, Vernooij RW, Fuentes Padilla P, et al. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017 Nov 22;(11):CD012884.

• 全文
• 摘要

59.  Xia CF, Arteaga J, Chen G, et al. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement. 2013 Nov;9(6):666-76.

• 全文
• 摘要

60.  Okamura N, Furumoto S, Fodero-Tavoletti MT, et al. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain. 2014 Jun;137(Pt 6):1762-71.

• 全文
• 摘要

61.  Maruyama M, Shimada H, Suhara T, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013 Sep 18;79(6):1094-108.

• 全文
• 摘要

62.  Chien DT, Bahri S, Szardenings AK, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis. 2013;34(2):457-68.

• 摘要

63.  Oudshoorn C, Mattace-Raso FU, van der Velde N, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25(6):539-43.

• 摘要

64.  Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010 Jul 12;170(13):1135-41.

• 全文
• 摘要

65.  Annweiler C, Schott AM, Berrut G, et al. Vitamin D and ageing: neurological issues. Neuropsychobiology. 2010 Aug;62(3):139-50.

• 全文
• 摘要

66.  Irani SR, Vincent A. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Arq Neuropsiquiatr. 2012 Apr;70(4):300-4.

• 全文
• 摘要

67.  Rosenbloom MH, Smith S, Akdal G, Geschwind MD. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.

• 全文
• 摘要

68.  DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011 Oct 20;72(2):245-56.

• 全文
• 摘要

69.  Liu Y, Yu JT, Zong Y, et al. C9ORF72 mutations in neurodegenerative diseases. Mol Neurobiol. 2014 Feb;49(1):386-98.

• 摘要

70.  Cooper-Knock J, Shaw PJ, Kirby J. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 2014 Mar;127(3):333-45.

• 全文
• 摘要

71.  Devenney E, Hornberger M, Irish M, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014 Mar;71(3):331-9.

• 摘要

72.  Gijselinck I, Van Langenhove T, van der Zee J, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012 Jan;11(1):54-65.

• 摘要

73.  Donnelly CJ, Zhang PW, Pham JT, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013 Oct 16;80(2):415-28.

• 全文
• 摘要

74.  Gendron TF, Bieniek KF, Zhang YJ, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013 Dec;126(6):829-44.

• 全文
• 摘要

75.  Mori K, Weng SM, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013 Mar 15;339(6125):1335-8.

• 摘要

76.  MacLeod R, Tibben A, Frontali M, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013 Mar;83(3):221-31.

• 全文
• 摘要

77.  Williams MA, Thomas G, de Lateur B, et al. Objective assessment of gait in normal-pressure hydrocephalus. Am J Phys Med Rehabil. 2008 Jan;87(1):39-45.

• 摘要

78.  Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):503-6.

• 全文
• 摘要

79.  Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist. 2005 Nov;11(6):348-61.

• 摘要

80.  Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4703-7.

• 全文
• 摘要

81.  Ritchie C, Smailagic N, Noel-Storr AH, et al. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017 Mar 22;(3):CD010803.

• 全文
• 摘要

82.  Knopman DS. Cerebrovascular disease and dementia. Br J Radiol. 2007 Dec;80 Spec No 2:S121-7.

• 摘要

83.  Metzler-Baddeley C. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia. Cortex. 2007 Jul;43(5):583-600.

• 摘要

84.  Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13;68(11):812-9.

• 摘要

85.  Feinberg TE, Farah MJ, eds. Behavioral neurology and neuropsychology. New York, NY: McGraw-Hill; 1997.

86.  Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003 Apr 8;60(7):1094-7.

• 摘要

87.  Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546-54.

• 摘要

88.  Miller BL, Gearhart R. Neuroimaging in the diagnosis of frontotemporal dementia. Dement Geriatr Cogn Disord. 1999;10(suppl 1):71-4.

• 摘要

89.  Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology. 1998 Jun;50(6):1541-5.

• 摘要

90.  Seeley WW, Bauer AM, Miller BL, et al. The natural history of temporal variant frontotemporal dementia. Neurology. 2005 Apr 26;64(8):1384-90.

• 全文
• 摘要

91.  Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7.

• 摘要

92.  Goldman JS, Miller BL, Safar J, et al. When sporadic disease is not sporadic: the potential for genetic etiology. Arch Neurol. 2004 Feb;61(2):213-6.

• 全文
• 摘要

93.  Fogel B, Wu M, Kremen S, et al. Creutzfeldt-Jakob disease presenting with alien limb sign. Mov Disord. 2006 Jul;21(7):1040-2.

• 摘要

94.  Carswell C, Thompson A, Lukic A, et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol. 2012 Dec 5;12:153.

• 全文
• 摘要

95.  Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May 17;76(20):1711-9.

• 全文
• 摘要

96.  Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62.

• 全文
• 摘要

97.  Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006 Sep;129(Pt 9):2278-87.

• 全文
• 摘要

98.  Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004 Nov;56(5):702-8.

• 摘要

99.  Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003 Jun;60(6):813-6.

• 全文
• 摘要

100.  Hamlin C, Puoti G, Berri S, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012 Aug 7;79(6):547-52.

• 全文
• 摘要

101.  Forner SA, Takada LT, Bettcher BM, et al. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract. 2015 Apr;5(2):116-125.

• 全文
• 摘要

102.  Sano K, Satoh K, Atarashi R, et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One. 2013;8(1):e54915.

• 全文
• 摘要

103.  Orrú CD, Bongianni M, Tonoli G, et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014 Aug 7;371(6):519-29.

• 全文
• 摘要

104.  McGuire LI, Peden AH, Orrú CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012 Aug;72(2):278-85.

• 全文
• 摘要

105.  Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011 Feb;17(2):175-8.

• 摘要

106.  Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008 Mar;14(2):100-7.

• 摘要

107.  Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1974 Feb;37(2):121-30.

• 全文
• 摘要

108.  Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999 Sep;246(suppl 2):II1-5.

• 摘要

109.  Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964 Apr;10:333-59.

• 摘要

110.  Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997 Jan;120 (Pt 1):65-74.

• 全文
• 摘要

111.  Esmonde T, Giles E, Gibson M, et al. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol. 1996 Sep;243(9):638-43.

• 摘要

112.  Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006 Jan;63(1):81-6.

• 全文
• 摘要

113.  Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54(suppl 5):S15-9.

• 摘要

114.  Sha S, Hou C, Viskontas IV, et al. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? Nat Clin Pract Neurol. 2006 Dec;2(12):658-65.

• 摘要

115.  Tree JJ, Kay J. Longitudinal assessment of language and memory impairments in pathologically confirmed cortico-basal ganglionic degeneration. Cortex. 2008 Oct;44(9):1234-47.

• 摘要

116.  Halavaara J, Brander A, Lyytinen J, et al. Wernicke's encephalopathy: is diffusion-weighted MRI useful? Neuroradiology. 2003 Aug;45(8):519-23.

• 摘要

117.  Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep. 2008 Sep;8(5):371-6.

• 全文
• 摘要

118.  Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005 Sep;57(3 suppl):S4-16.

• 摘要

119.  Qureshi AI, Williams MA, Razumovsky AY, et al. Magnetic resonance imaging, unstable intracranial pressure and clinical outcome in patients with normal pressure hydrocephalus. Acta Neurochir Suppl. 1998;71:354-6.

• 摘要

120.  Virhammar J, Cesarini KG, Laurell K. The CSF tap test in normal pressure hydrocephalus: evaluation time, reliability and the influence of pain. Eur J Neurol. 2012 Feb;19(2):271-6.

• 摘要

121.  Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007 Jun;13(3):203-9.

• 摘要

122.  McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005 Sep;4(9):543-55.

• 摘要

123.  Grossman RI , Yousem DM, eds. Neuroradiology: the requisites. 2nd ed. Philadelphia, PA: Mosby; 2003.

124.  Adams RD, Victor M, Ropper AH. Principles of neurology. 6th ed. New York, NY: McGraw-Hill; 1997:877.

125.  Kingston M, French P, Higgins S, et al; British Association for Sexual Health and HIV. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016 May;27(6):421-46.

• 全文
• 摘要

126.  Pope V, Fears MB, Morrill WE, et al. Comparison of the Serodia Treponema pallidum particle agglutination, Captia Syphilis-G, and SpiroTek Reagin II tests with standard test techniques for diagnosis of syphilis. J Clin Microbiol. 2000 Jul;38(7):2543-5.

• 全文
• 摘要

127.  Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006 Jun;33(3):270-98.

• 摘要

128.  Rosenbloom MH, Smith S, Akdal G, et al. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.

• 全文
• 摘要

129.  Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008 Oct;65(10):1341-6.

• 全文
• 摘要

130.  Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 Mar;127(Pt 3):701-12.

• 全文
• 摘要

131.  Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002 May;51(5):625-30.

• 摘要

132.  Ropper AH, Gorson KC. Clinical practice: concussion. N Engl J Med. 2007 Jan 11;356(2):166-72.

• 全文
• 摘要

133.  Guo Z, Cupples LA, Kurz A, et al. Head injury and the risk of AD in the MIRAGE study. Neurology. 2000 Mar 28;54(6):1316-23.

• 摘要

134.  Samuels MA, Feske S, eds. Office practice of neurology. 2nd ed. New York, NY: Churchill Livingstone; 2003.

135.  Bradley W, Daroff RB, Fenichel G, et al, eds. Neurology in clinical practice. 4th ed. Philadelphia, PA: Butterworth Heinemann; 2004.

136.  Carrera E, Bogousslavsky J. The thalamus and behavior: effects of anatomically distinct strokes. Neurology. 2006 Jun 27;66(12):1817-23.

• 摘要

137.  Leritz EC, Grande LJ, Bauer RM. Temporal lobe epilepsy as a model to understand human memory: the distinction between explicit and implicit memory. Epilepsy Behav. 2006 Aug;9(1):1-13.

• 摘要

138.  Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70.

• 摘要

139.  Sander K, Sander D. New insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol. 2005 Jul;4(7):437-44.

• 摘要

140.  Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006 Jul;129(Pt 7):1640-58.

• 全文
• 摘要

141.  Peterson RC. Mild cognitive impairment. Continuum Lifelong Learning Neurol. 2007;13:15-38.

142.  Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999 Apr 22;52(7):1397-403.

• 全文
• 摘要

143.  Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995 Apr 26;273(16):1274-8.

• 摘要

144.  Aggarwal NT, Wilson RS, Beck TL, et al. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb;11(1):3-7.

• 摘要

145.  Orrison WW, Hanson EH, Alamo T, et al. Traumatic brain injury: a review and high-field MRI findings in 100 unarmed combatants using a literature-based checklist approach. J Neurotrauma. 2009 May;26(5):689-701.

• 摘要

146.  McCrory P, Zazryn T, Cameron P. The evidence for chronic traumatic encephalopathy in boxing. Sports Med. 2007;37(6):467-76.

• 摘要

147.  Handratta V, Hsu E, Vento J, et al. Neuroimaging findings and brain-behavioral correlates in a former boxer with chronic traumatic brain injury. Neurocase. 2010 Apr;16(2):125-34.

• 摘要

148.  National Institute for Health and Care Excellence. Head injury: assessment and early management. June 2017 [internet publication].

• 全文